(Q36338314)

13 August 2017

title

Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma (English)

1 reference

13 August 2017

1 reference

head and neck carcinoma

1 reference

inferred from title

author name string

Montserrat Vera-Llonch

1

1 reference

13 August 2017

Gerry Oster

2

1 reference

13 August 2017

May Hagiwara

3

1 reference

13 August 2017

Stephen Sonis

4

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 January 2006

1 reference

13 August 2017

1 reference

13 August 2017

volume

106

1 reference

13 August 2017

issue

2

1 reference

13 August 2017

page(s)

329-336

1 reference

Complications of radiation therapy for head and neck cancers. The patient's perspective.

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21622

7 January 2021

Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21622

7 January 2021

Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21622

7 January 2021

Chemotherapy- and radiotherapy-induced mucositis in head and neck cancer patients: new trends in pathophysiology, prevention and treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21622

7 January 2021

Risk factors for ulcerative oral mucositis in cancer patients: unanswered questions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21622

7 January 2021

Mechanisms for radiation-induced oral mucositis and the consequences

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21622

7 January 2021

Single fraction per day versus two fractions per day versus radiochemotherapy in the treatment of head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21622

7 January 2021

Placebo-controlled randomized trial of infusional fluorouracil during standard radiotherapy in locally advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21622

7 January 2021

Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: update of a Northern California Oncology Group randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21622

7 January 2021

Randomized clinical trial of mitomycin C as an adjunct to radiotherapy in head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21622

7 January 2021

Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced squamous cell carcinoma of the head and neck: preliminary report of a randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21622

7 January 2021

Combined chemotherapy and radiation therapy in advanced inoperable squamous cell carcinoma of the head and neck. The final report of a randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21622

7 January 2021

Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21622

7 January 2021

A randomized trial of neoadjuvant vs concomitant chemotherapy vs radiotherapy alone in the treatment of stage IV head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21622

7 January 2021

Mitomycin C as an adjunct to postoperative radiation therapy in squamous cell carcinoma of the head and neck: results from two randomized clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21622

7 January 2021

Radiotherapy, combined with simultaneous chemotherapy with mitomycin C and bleomycin for inoperable head and neck cancer--preliminary report

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21622

7 January 2021

Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21622

7 January 2021

Concomitant boost technique using accelerated superfractionated radiation therapy for advanced squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21622

7 January 2021

Prospective randomized trial comparing hyperfractionated versus conventional radiotherapy in stages III and IV oropharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21622

7 January 2021

Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21622

7 January 2021

A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21622

7 January 2021

Identifiers

DOI

10.1002/CNCR.21622

1 reference

13 August 2017

1 reference